Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women

Inclusion Criteria:

• Must be between the ages of 30 to 65 years

• Must have undergone hysterectomy and bilateral salpingo-oophorectomy

Exclusion Criteria:

• A history of allergic reactions to androgens (oral or patch), topical alcohol, or anycomponent of the formulation

• Any systemic skin diseases or local skin abnormalities in the area of application

• Diagnosed with another primary female sexual dysfunction (e.g., Sexual AversionDisorder, Female Sexual Arousal Disorder).

• A medical condition that could affect or interfere with sexual function

• Using a systemic transdermal gel or cream estrogen therapy.